Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Oral Lacosamide in Young Children With Epilepsy (Extension of EP0034/SP848)
2022-502639-21-00Phase 3Completed
- Sponsor
- UCB
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 3, open-label, single-arm trial of lacosamide in epilepsy, sponsored by UCB. Started Mar 2023; status: completed.
02
Drugs
lacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2022-502639-21-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-502639-21-00.